Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-12-31

Clinical Trial Update: Neoadjuvant Chemotherapy Plus Chemoradiation in Patients With Potentially Resectable Gastric Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating neoadjuvant chemotherapy plus chemoradiation for potentially resectable gastric cancer; the trial status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fudan University | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN